431: PARENTERAL ANTIPLATELET USE IN THE NEUROCRITICAL CARE PATIENT POPULATION AND ASSOCIATED OUTCOMES
Benjamin Meola, Grace Conroy, Christine Ahrens, Stephanie Bass et autres
Introduction: Cangrelor and tirofiban are agents used in percutaneous coronary interventions (PCI) to reduce the risk of periprocedural thromboembolic complications. To this point, there have only been retrospective reviews and case reports investigating their use in neuroendovascular procedures or bridging in the …
us (code pays fourni par la source)